24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS C
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01517308 |
Recruitment Status
:
Withdrawn
(Time elapsed to require permissions and a recent paper showed a high efficacy of a 48-week regimen in this setting. It seems non-ethical to start this trial)
First Posted
: January 25, 2012
Last Update Posted
: March 19, 2012
|
Sponsor:
Federico II University
Information provided by (Responsible Party):
Prof. Guglielmo Borgia, Federico II University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : | Withdrawn |
---|---|
Estimated Primary Completion Date : | November 2015 |
Estimated Study Completion Date : | November 2015 |